Zwaan CM - Search Results

1

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.

Coenen EA, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Lo Nigro L, Morimoto A, Perot C, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM. Coenen EA, et al. Among authors: zwaan cm. Blood. 2011 Jun 30;117(26):7102-11. doi: 10.1182/blood-2010-12-328302. Epub 2011 May 6. Blood. 2011. PMID: 21551233 Free PMC article.

2

Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.

den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ. den Boer ML, et al. Among authors: zwaan cm. Blood. 1998 Mar 15;91(6):2092-8. Blood. 1998. PMID: 9490695 Free article.

3

Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study.

Kaspers GJ, Zwaan CM, Veerman AJ, Rots MG, Pieters R, Bucsky P, Domula M, Göbel U, Graf N, Havers W, Jorch N, Kabisch K, Spaar HJ, Ritter J, Creutzig U. Kaspers GJ, et al. Among authors: zwaan cm. Klin Padiatr. 1999 Jul-Aug;211(4):239-44. doi: 10.1055/s-2008-1043795. Klin Padiatr. 1999. PMID: 10472557 Review.

4

Resistance testing and mechanisms of resistance in childhood leukemia. Studies from Amsterdam.

Pieters R, Kaspers GJ, Ramakers-van Woerden NL, den Boer ML, Rots MG, Zwaan CM, Haarman EG, Veerman AJ. Pieters R, et al. Among authors: zwaan cm. Adv Exp Med Biol. 1999;457:391-5. doi: 10.1007/978-1-4615-4811-9_41. Adv Exp Med Biol. 1999. PMID: 10500814 Review. No abstract available.

5

Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays.

Kaspers GJ, Zwaan CM, Pieters R, Veerman AJ. Kaspers GJ, et al. Among authors: zwaan cm. Adv Exp Med Biol. 1999;457:415-21. Adv Exp Med Biol. 1999. PMID: 10500817 Review.

6

Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.

Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wünsche R, Rottier MM, Hählen K, van Wering ER, Janka-Schaub GE, Creutzig U, Veerman AJ. Zwaan CM, et al. Blood. 2000 Oct 15;96(8):2879-86. Blood. 2000. PMID: 11023525 Free article.

7

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.

Zwaan CM, Kaspers GJ, Pieters R, Hählen K, Janka-Schaub GE, van Zantwijk CH, Huismans DR, de Vries E, Rots MG, Peters GJ, Jansen G, Creutzig U, Veerman AJ. Zwaan CM, et al. Blood. 2002 Jan 1;99(1):245-51. doi: 10.1182/blood.v99.1.245. Blood. 2002. PMID: 11756178 Free article.

8

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.

Zwaan CM, Kaspers GJ, Pieters R, Hählen K, Huismans DR, Zimmermann M, Harbott J, Slater RM, Creutzig U, Veerman AJ. Zwaan CM, et al. Blood. 2002 Nov 1;100(9):3352-60. doi: 10.1182/blood.V100.9.3352. Blood. 2002. PMID: 12384437 Free article.

9

Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis.

Zwaan CM, Reinhardt D, Corbacioglu S, van Wering ER, Bökkerink JP, Tissing WJ, Samuelsson U, Feingold J, Creutzig U, Kaspers GJ. Zwaan CM, et al. Blood. 2003 May 15;101(10):3868-71. doi: 10.1182/blood-2002-07-1947. Epub 2003 Jan 23. Blood. 2003. PMID: 12543868 Free article. Clinical Trial.

10

FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.

Zwaan CM, Meshinchi S, Radich JP, Veerman AJ, Huismans DR, Munske L, Podleschny M, Hählen K, Pieters R, Zimmermann M, Reinhardt D, Harbott J, Creutzig U, Kaspers GJ, Griesinger F. Zwaan CM, et al. Blood. 2003 Oct 1;102(7):2387-94. doi: 10.1182/blood-2002-12-3627. Epub 2003 Jun 19. Blood. 2003. PMID: 12816873 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters